CymaBay Therapeutics Inc CBAY
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- — / —
- Shares Outstanding
- 114.79M
- Market Cap
- —
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 111.01
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
CymaBay Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing therapies for patients with liver and other chronic diseases with high unmet medical need. Its product in pipeline includes two clinical stage product candidates: seladelpar (a PPARd agonist) and MBX-2982 (a GPR119 agonist).
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Growth
- Total Number of Employees
- 101
- Website
- https://www.cymabay.com
Valuation
|
Metric
|
CBAY
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 12.65 |
Price/Sales | 111.01 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
CBAY
|
|---|---|
Quick Ratio | 10.70 |
Current Ratio | 10.96 |
Interest Coverage | −5.27 |
Quick Ratio
CBAY
Profitability
|
Metric
|
CBAY
|
|---|---|
Return on Assets (Normalized) | −30.06% |
Return on Equity (Normalized) | −51.97% |
Return on Invested Capital (Normalized) | −30.87% |
Return on Assets
CBAY
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|QbMfc>% | LOCK|Hvs$B | $133B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|#^@&P%c | LOCK|Jw^> | $83B | |||
| Moderna Inc
MRNA
| LOCK|fHFY>> | LOCK|T< | $80B | |||
| argenx SE ADR
ARGX
| LOCK|xcm<&<Z | LOCK|#$R | $55B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|T!J&mLp | LOCK|&t | $45B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|B?Xx%T | LOCK|hjBpJ | $30B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|kNZ<^&t | LOCK|^@<G | $28B | |||
| Incyte Corp
INCY
| LOCK|#>qxCz | LOCK|M# | $23B | |||
| BioNTech SE ADR
BNTX
| LOCK|YtR>XM | LOCK|?> | $22B | |||
| Jazz Pharmaceuticals PLC
JAZZ
| LOCK|tTlJQK | LOCK|Jj! | $14B |
United States